Syntr Health Technologies develops a point-of-care medical device for processing autologous adipose (fat) tissue. Its core product is the patented, FDA-cleared SyntrFuge System™, a single-use disposable device for harvesting, concentrating and transferring autologous adipose tissue. The company also released and listed with the FDA its Class I SyntrFPU 360 reusable lab centrifuge as an accessory to the SyntrFuge System. Syntr is headquartered at University Lab Partners in Irvine/Orange County, California, and is led by CEO Ahmed Zobi. The company plans to use newly raised capital to build out sales for the SyntrFuge System across surgical specialties where adipose transfer is desired. Recently Syntr added Dane Shackleford to its board of directors to support commercial efforts.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2021